Skup podataka
Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein
Institut Ruđer Bošković, 2021. urn:nbn:hr:241:733364
Tomić, Draško

 Skup podataka
Skup podataka: covid-19_results_mar_dec_2020.zip, 1.22 GB
Pravo pristupa: Otvoren pristup

Dokumentacija: efficacy_of_fda_approved_hiv_drugs_on_sars-cov-2.txt, 720 bytes
Pravo pristupa: Otvoren pristup
Opis datoteke:
Methodology description (engleski)

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Citirajte ovaj rad

Tomić, D. (2021). Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein [Skup podataka]. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, Draško. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković, 2021. 08.12.2024. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, Draško. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić, D. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. [Online]. [Citirano 08.12.2024.]. Preuzeto s: https://urn.nsk.hr/urn:nbn:hr:241:733364.

Tomić D. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. [Internet]. Institut Ruđer Bošković: , HR; 2021, [pristupljeno 08.12.2024.] Dostupno na: https://urn.nsk.hr/urn:nbn:hr:241:733364.

D. Tomić, Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein, Institut Ruđer Bošković, 2021. Citirano: 08.12.2024. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:241:733364.

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:241:733364
Naslov (engleski)Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein
AutorDraško Tomić
Institut Ruđer Bošković
Ruđer Bošković Institute
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Genetika, genomika i proteomika čovjeka
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Farmacija
Medicinska biokemija
Znanstveno / umjetničko
područje, polje i grana		BIOTEHNIČKE ZNANOSTI
Biotehnologija
Bioinformatika
Sažetak (engleski)
These results were obtained using the Vini in silico model of cancer in the period from March to December 2020. The efficacy of 49 FDA-approved antiviral drugs on SARS-CoV-2 spike glycoprotein was analyzed. Based on the fact that HIV drugs showed the highest efficacy, the efficacy of their double and triple combinations was further calculated.
Metodologija (engleski)These results were obtained using the Vini in silico model of cancer in the period from March to December 2020. The efficacy of 49 FDA-approved antiviral drugs on SARS-CoV-2 spike glycoprotein has analyzed with the Vini in silico model of cancer. Based on the fact that HIV drugs showed the highest efficacy, the efficacy of their double and triple combinations was further calculated. Finally, 10 most effective HIV drug combinations were finally examined on their possible adverse effects with Medscape and Lexicomp software.
Ključne riječi (engleski)
Jezikengleski
URN:NBNurn:nbn:hr:241:733364
Datum objave2021-01-18
GeolokacijaHrvatska
ProjektŠifra: KK.01.1.1.01.009
Naziv (hrvatski): Napredne metode i tehnologije u znanosti o podatcima i kooperativnim sustavima-DATACROSS
Kratica: DATACROSS
Voditelj: Sven Lončarić; Petrović Ivan
Pravna nadležnost: eu
Financijer: EC
IzdavačInstitut Ruđer Bošković
Ruđer Bošković Institute
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje 4.0 međunarodna (CC BY 4.0)
Datum i vrijeme pohrane2021-03-01 13:35:10